Reaction
Muscle Discomfort reporting signals
As of the last recalculation, Muscle Discomfort appears in 762 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is INCLISIRAN (PRR 48.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Inclisiran | 14 | 48.6 | 48.6 |
| Ravulizumab | 12 | 24.6 | 24.6 |
| Ezetimibe | 54 | 21.1 | 21.1 |
| Asfotase Alfa | 6 | 16.5 | 16.5 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 5 | 16.0 | 16.0 |
| Relugolix | 10 | 11.7 | 11.7 |
| Alirocumab | 7 | 7.7 | 7.7 |
| Abaloparatide | 7 | 6.5 | 6.5 |
| Evolocumab | 20 | 3.4 | 3.4 |